Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Consensus | Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | $705.13M | $26.51 | $53.00 | 99.92% | Strong Buy | 4 | 48.55% | 79.94% | N/A | N/A | |
HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.24B | $37.35 | $59.43 | 59.11% | Strong Buy | 7 | 23.27% | 14.55% | N/A | N/A | |
VYGR | VOYAGER THERAPEUTICS INC | $337.81M | $7.70 | $16.00 | 107.93% | Strong Buy | 3 | -70.03% | N/A | N/A | N/A | |
OCUP | OCUPHIRE PHARMA INC | $83.19M | $3.96 | $18.50 | 367.17% | Strong Buy | 2 | 15.96% | -48.65% | N/A | N/A | |
UTHR | UNITED THERAPEUTICS CORP | $10.51B | $223.93 | $297.17 | 32.71% | Strong Buy | 6 | 8.30% | 6.42% | N/A | N/A | |
KNSA | KINIKSA PHARMACEUTICALS LTD | $1.19B | $16.93 | $32.00 | 89.01% | Strong Buy | 1 | 23.76% | N/A | N/A | N/A | |
BMRN | BIOMARIN PHARMACEUTICAL INC | $16.63B | $88.38 | $113.41 | 28.32% | Buy | 17 | 21.17% | 99.74% | N/A | N/A | |
TECH | BIO-TECHNE CORP | $11.21B | $70.87 | $101.50 | 43.22% | Strong Buy | 4 | 21.86% | 22.81% | 21.96% | 16.36% | |
GMAB | GENMAB A | $24.72B | $37.43 | $45.50 | 21.56% | Buy | 4 | 14.45% | 29.05% | N/A | N/A | |
ICPT | INTERCEPT PHARMACEUTICALS INC | $452.09M | $10.82 | $23.00 | 112.57% | Buy | 8 | 35.12% | 6.32% | N/A | N/A | |
CPRX | CATALYST PHARMACEUTICALS INC | $1.30B | $12.18 | $25.00 | 105.25% | Strong Buy | 3 | -3.72% | -3.96% | N/A | N/A | |
PGEN | PRECIGEN INC | $357.68M | $1.40 | $10.00 | 614.29% | Buy | 2 | 32.54% | N/A | N/A | N/A | |
LGND | LIGAND PHARMACEUTICALS INC | $1.06B | $61.06 | $116.33 | 90.52% | Strong Buy | 3 | 24.35% | 8.92% | N/A | N/A | |
INCY | INCYTE CORP | $13.53B | $60.37 | $82.55 | 36.73% | Buy | 11 | 13.61% | 68.58% | N/A | N/A | |
TBPH | THERAVANCE BIOPHARMA INC | $478.49M | $9.06 | $20.00 | 120.75% | Buy | 1 | 28.42% | N/A | N/A | N/A | |
HALO | HALOZYME THERAPEUTICS INC | $5.22B | $39.60 | $56.00 | 41.41% | Strong Buy | 6 | 16.01% | 46.34% | N/A | N/A | |
CMRX | CHIMERIX INC | $93.46M | $1.06 | $8.00 | 658.29% | Buy | 3 | -18.73% | N/A | N/A | N/A | |
LIFE | ATYR PHARMA INC | $92.41M | $1.62 | $24.67 | 1,422.65% | Strong Buy | 3 | 58.60% | N/A | N/A | N/A | |
EXEL | EXELIXIS INC | $6.85B | $21.51 | $25.63 | 19.13% | Strong Buy | 8 | 13.35% | 58.22% | N/A | N/A | |
VNDA | VANDA PHARMACEUTICALS INC | $246.14M | $4.28 | N/A | N/A | N/A | N/A | 5.16% | 5.46% | N/A | N/A | |
MRNA | MODERNA INC | $39.40B | $103.53 | $142.33 | 37.48% | Buy | 9 | -0.04% | 20.78% | N/A | N/A | |
ZYME | ZYMEWORKS INC | $450.37M | $6.64 | $13.20 | 98.80% | Buy | 5 | -34.31% | N/A | N/A | N/A | |
LPCN | LIPOCINE INC | $17.12M | $3.22 | $33.00 | 924.84% | Strong Buy | 1 | 1,792.74% | N/A | 28.49% | 26.68% | |
APRE | APREA THERAPEUTICS INC | $16.25M | $4.35 | $20.00 | 359.77% | Buy | 1 | 786.80% | N/A | N/A | N/A | |
CLGN | COLLPLANT BIOTECHNOLOGIES LTD | $69.57M | $6.10 | $11.00 | 80.33% | Buy | 1 | 142.67% | N/A | N/A | N/A | |
PRTA | PROTHENA CORP PUBLIC LTD CO | $2.81B | $52.50 | $88.40 | 68.38% | Buy | 5 | 58.57% | N/A | N/A | N/A | |
CLNN | CLENE INC | $61.89M | $0.48 | $7.20 | 1,393.78% | Strong Buy | 5 | 810.63% | N/A | N/A | N/A | |
GTHX | G1 THERAPEUTICS INC | $69.34M | $1.34 | $11.40 | 750.75% | Buy | 5 | 36.53% | N/A | N/A | N/A | |
ENTX | ENTERA BIO LTD | $19.74M | $0.69 | $10.00 | 1,359.85% | Buy | 1 | 601.97% | N/A | N/A | N/A | |
GNFT | GENFIT SA | $185.39M | $3.72 | $11.00 | 195.70% | Buy | 1 | 37.80% | N/A | N/A | N/A | |
AGIO | AGIOS PHARMACEUTICALS INC | $1.37B | $24.56 | $37.00 | 50.65% | Buy | 2 | 119.91% | N/A | N/A | N/A | |
NRBO | NEUROBO PHARMACEUTICALS INC | $20.33M | $0.53 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
VRCA | VERRICA PHARMACEUTICALS INC | $168.26M | $4.00 | $11.50 | 187.50% | Strong Buy | 4 | 136.89% | N/A | N/A | N/A | |
CRSP | CRISPR THERAPEUTICS AG | $3.70B | $46.56 | $71.00 | 52.49% | Buy | 14 | 109.39% | N/A | N/A | N/A | |
SELB | SELECTA BIOSCIENCES INC | $164.17M | $1.07 | $3.25 | 203.74% | Buy | 4 | 20.14% | N/A | N/A | N/A | |
CRDF | CARDIFF ONCOLOGY INC | $72.82M | $1.63 | $12.00 | 636.20% | Buy | 1 | 269.34% | N/A | N/A | N/A | |
STOK | STOKE THERAPEUTICS INC | $196.50M | $4.44 | $22.17 | 399.26% | Buy | 6 | 76.80% | N/A | N/A | N/A | |
BCYC | BICYCLE THERAPEUTICS PLC | $894.27M | $21.59 | $49.00 | 126.96% | Strong Buy | 8 | 40.29% | N/A | N/A | N/A | |
AUPH | AURINIA PHARMACEUTICALS INC | $1.20B | $8.34 | $15.00 | 79.86% | Strong Buy | 2 | 47.67% | N/A | N/A | N/A | |
AUTL | AUTOLUS THERAPEUTICS PLC | $481.10M | $2.77 | $7.50 | 170.76% | Strong Buy | 4 | 174.11% | N/A | N/A | N/A | |
CARM | CARISMA THERAPEUTICS INC | $178.06M | $4.42 | $11.00 | 148.87% | Buy | 3 | 36.40% | N/A | N/A | N/A | |
VBLT | VASCULAR BIOGENICS LTD | $17.16M | $0.22 | N/A | N/A | N/A | N/A | 8.19% | N/A | N/A | N/A | |
ORTX | ORCHARD THERAPEUTICS PLC | $160.42M | $7.06 | $24.50 | 247.03% | Strong Buy | 2 | 54.73% | N/A | -562.62% | -264.11% | |
ZLAB | ZAI LAB LTD | $2.50B | $25.39 | $87.50 | 244.62% | Strong Buy | 3 | 81.16% | N/A | N/A | N/A | |
ALLO | ALLOGENE THERAPEUTICS INC | $631.95M | $3.77 | $18.06 | 378.94% | Buy | 9 | 818.01% | N/A | N/A | N/A | |
XENE | XENON PHARMACEUTICALS INC | $2.30B | $35.84 | $51.67 | 44.16% | Strong Buy | 6 | 748.34% | N/A | N/A | N/A | |
SPRO | SPERO THERAPEUTICS INC | $64.82M | $1.23 | $7.00 | 469.11% | Buy | 1 | N/A | N/A | N/A | N/A | |
AXSM | AXSOME THERAPEUTICS INC | $3.48B | $73.70 | $108.43 | 47.12% | Strong Buy | 7 | 50.90% | N/A | N/A | N/A | |
EDIT | EDITAS MEDICINE INC | $648.98M | $7.95 | $14.00 | 76.10% | Buy | 6 | 83.65% | N/A | N/A | N/A | |
SLGL | SOL-GEL TECHNOLOGIES LTD | $58.67M | $2.11 | $9.50 | 350.24% | Strong Buy | 2 | 120.97% | N/A | N/A | N/A | |
DNLI | DENALI THERAPEUTICS INC | $3.05B | $22.22 | $65.00 | 192.53% | Strong Buy | 6 | -3.45% | N/A | N/A | N/A | |
ONTX | ONCONOVA THERAPEUTICS INC | $15.98M | $0.76 | $11.00 | 1,343.57% | Buy | 1 | 32.74% | N/A | -120.99% | -75.05% | |
VRNA | VERONA PHARMA PLC | $1.35B | $16.94 | $32.25 | 90.38% | Strong Buy | 4 | 646.96% | N/A | N/A | N/A | |
CARA | CARA THERAPEUTICS INC | $96.80M | $1.79 | $16.50 | 821.79% | Buy | 6 | 121.89% | N/A | N/A | N/A | |
LUMO | LUMOS PHARMA INC | $23.01M | $2.90 | $18.33 | 532.17% | Strong Buy | 3 | 143.98% | N/A | N/A | N/A | |
DOMH | DOMINARI HOLDINGS INC | $13.68M | $2.56 | N/A | N/A | N/A | N/A | 28,069.01% | N/A | -19.12% | -17.45% | |
BNTX | BIONTECH SE | $26.04B | $108.61 | $150.73 | 38.78% | Buy | 11 | -32.29% | -60.03% | N/A | N/A | |
MDWD | MEDIWOUND LTD | $65.63M | $9.05 | $29.50 | 225.97% | Buy | 2 | 32.16% | N/A | N/A | N/A | |
CGEN | COMPUGEN LTD | $90.00M | $1.02 | $8.00 | 684.31% | Strong Buy | 3 | 104.25% | N/A | N/A | N/A | |
VRDN | VIRIDIAN THERAPEUTICS INC | $714.88M | $16.37 | $42.56 | 159.96% | Strong Buy | 9 | 358.06% | N/A | N/A | N/A | |
PLUR | PLURI INC | $24.81M | $0.60 | N/A | N/A | N/A | N/A | 251.99% | N/A | 1,531.15% | 402.55% | |
PLX | PROTALIX BIOTHERAPEUTICS INC | $122.40M | $1.71 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
CORT | CORCEPT THERAPEUTICS INC | $3.29B | $32.04 | $30.40 | -5.12% | Buy | 5 | 10.80% | 26.58% | N/A | N/A | |
MGNX | MACROGENICS INC | $281.25M | $4.54 | $12.00 | 164.32% | Strong Buy | 3 | 29.44% | N/A | N/A | N/A | |
DTIL | PRECISION BIOSCIENCES INC | $49.48M | $0.43 | $2.50 | 481.40% | Strong Buy | 2 | 65.68% | N/A | N/A | N/A | |
MRKR | MARKER THERAPEUTICS INC | $47.13M | $5.35 | N/A | N/A | N/A | N/A | 73.14% | N/A | N/A | N/A | |
QURE | UNIQURE NV | $356.35M | $7.47 | $41.00 | 448.86% | Strong Buy | 6 | 22.12% | N/A | N/A | N/A | |
RNA | AVIDITY BIOSCIENCES INC | $523.12M | $7.06 | $31.60 | 347.59% | Strong Buy | 5 | 184.46% | N/A | N/A | N/A | |
FULC | FULCRUM THERAPEUTICS INC | $273.87M | $4.43 | $11.00 | 148.31% | Buy | 4 | 94.44% | N/A | N/A | N/A | |
MRSN | MERSANA THERAPEUTICS INC | $153.04M | $1.27 | $4.60 | 262.20% | Hold | 5 | 56.92% | N/A | N/A | N/A | |
SAGE | SAGE THERAPEUTICS INC | $1.19B | $19.90 | $29.87 | 50.09% | Hold | 15 | 259.74% | N/A | N/A | N/A | |
REGN | REGENERON PHARMACEUTICALS INC | $90.28B | $831.62 | $907.89 | 9.17% | Strong Buy | 18 | 1.80% | 1.39% | N/A | N/A | |
BLUE | BLUEBIRD BIO INC | $336.90M | $3.15 | $6.70 | 112.76% | Buy | 6 | 165.53% | N/A | N/A | N/A | |
PULM | PULMATRIX INC | $7.93M | $2.17 | $10.00 | 360.83% | Buy | 1 | 24.89% | N/A | N/A | N/A | |
MESO | MESOBLAST LTD | $213.32M | $1.31 | $6.83 | 421.60% | Hold | 3 | 436.04% | N/A | 1,110.56% | 832.55% | |
DBVT | DBV TECHNOLOGIES SA | $282.02M | $1.47 | $7.00 | 377.82% | Buy | 2 | 201.62% | N/A | N/A | N/A | |
SEER | SEER INC | $150.26M | $2.35 | N/A | N/A | N/A | N/A | 90.24% | N/A | N/A | N/A | |
JANX | JANUX THERAPEUTICS INC | $451.24M | $9.78 | $29.50 | 201.64% | Buy | 2 | 342.04% | N/A | -48.38% | -42.42% | |
NRIX | NURIX THERAPEUTICS INC | $444.89M | $9.23 | $26.60 | 188.19% | Buy | 5 | 36.14% | N/A | N/A | N/A | |
IMGN | IMMUNOGEN INC | $3.64B | $14.64 | $23.00 | 57.16% | Strong Buy | 7 | 38.87% | N/A | N/A | N/A | |
AMLX | AMYLYX PHARMACEUTICALS INC | $1.25B | $18.57 | $49.67 | 167.53% | Strong Buy | 3 | 60.34% | N/A | N/A | N/A | |
CALT | CALLIDITAS THERAPEUTICS AB | $487.96M | $16.38 | $34.00 | 107.57% | Buy | 2 | 81.44% | N/A | N/A | N/A | |
TFFP | TFF PHARMACEUTICALS INC | $12.18M | $0.34 | $5.50 | 1,536.90% | Strong Buy | 2 | 471.77% | N/A | N/A | N/A | |
LQDA | LIQUIDIA CORP | $406.57M | $6.28 | $12.33 | 96.39% | Hold | 3 | 97.99% | N/A | N/A | N/A | |
IMNN | IMUNON INC | $10.21M | $1.09 | $12.00 | 1,000.92% | Buy | 1 | 283.06% | N/A | N/A | N/A | |
IGMS | IGM BIOSCIENCES INC | $406.81M | $6.97 | $20.67 | 196.51% | Buy | 6 | 292.50% | N/A | N/A | N/A | |
ACST | ACASTI PHARMA INC | $14.30M | $1.92 | N/A | N/A | N/A | N/A | N/A | N/A | 13.26% | 11.63% | |
SGMO | SANGAMO THERAPEUTICS INC | $149.13M | $0.84 | $6.07 | 621.02% | Buy | 7 | 11.29% | N/A | N/A | N/A | |
ENTA | ENANTA PHARMACEUTICALS INC | $265.72M | $12.62 | $31.60 | 150.40% | Hold | 5 | 93.62% | N/A | N/A | N/A | |
CLLS | CELLECTIS SA | $90.60M | $1.63 | $11.00 | 574.85% | Strong Buy | 3 | 108.25% | N/A | N/A | N/A | |
INO | INOVIO PHARMACEUTICALS INC | $104.55M | $0.39 | $2.00 | 412.82% | Hold | 1 | 86.57% | N/A | N/A | N/A | |
CRNX | CRINETICS PHARMACEUTICALS INC | $1.57B | $28.62 | $45.14 | 57.73% | Strong Buy | 7 | 116.77% | N/A | N/A | N/A | |
AADI | AADI BIOSCIENCE INC | $128.48M | $5.24 | $45.00 | 758.78% | Buy | 1 | 12.83% | N/A | N/A | N/A | |
NTLA | INTELLIA THERAPEUTICS INC | $3.01B | $33.99 | $75.77 | 122.92% | Strong Buy | 13 | 44.00% | N/A | N/A | N/A | |
MIRM | MIRUM PHARMACEUTICALS INC | $1.19B | $31.08 | $72.33 | 132.73% | Strong Buy | 3 | 58.24% | N/A | N/A | N/A | |
MIST | MILESTONE PHARMACEUTICALS INC | $97.81M | $2.93 | $14.00 | 377.82% | Buy | 3 | 201.85% | N/A | N/A | N/A | |
ARVN | ARVINAS INC | $1.30B | $24.23 | $62.30 | 157.12% | Strong Buy | 10 | 25.17% | N/A | N/A | N/A | |
LXRX | LEXICON PHARMACEUTICALS INC | $284.11M | $1.16 | $8.00 | 589.66% | Strong Buy | 1 | 701.33% | N/A | N/A | N/A | |
VIR | VIR BIOTECHNOLOGY INC | $1.26B | $9.37 | $35.83 | 282.42% | Buy | 6 | 4.38% | N/A | N/A | N/A | |
CUE | CUE BIOPHARMA INC | $104.76M | $2.33 | $11.00 | 372.10% | Strong Buy | 3 | 136.40% | N/A | N/A | N/A |